Chronic cocaine but not chronic amphetamine use is associated with perseverative responding in humans
Rationale Chronic drug use has been associated with increased impulsivity and maladaptive behaviour, but the underlying mechanisms of this impairment remain unclear. We investigated the ability to adapt behaviour according to changes in reward contingencies, using a probabilistic reversal-learning t...
Saved in:
Published in | Psychopharmacologia Vol. 197; no. 3; pp. 421 - 431 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Berlin/Heidelberg
Springer-Verlag
01.04.2008
Springer Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Rationale
Chronic drug use has been associated with increased impulsivity and maladaptive behaviour, but the underlying mechanisms of this impairment remain unclear. We investigated the ability to adapt behaviour according to changes in reward contingencies, using a probabilistic reversal-learning task, in chronic drug users and controls.
Materials and methods
Five groups were compared: chronic amphetamine users (
n
= 30); chronic cocaine users (
n
= 27); chronic opiate users (
n
= 42); former drug users of psychostimulants and opiates (
n
= 26); and healthy non-drug-taking control volunteers (
n
= 25). Participants had to make a forced choice between two alternative stimuli on each trial to acquire a stimulus–reward association on the basis of degraded feedback and subsequently to reverse their responses when the reward contingencies changed.
Results
Chronic cocaine users demonstrated little behavioural change in response to the change in reward contingencies, as reflected by perseverative responding to the previously rewarded stimulus. Perseverative responding was observed in cocaine users regardless of whether they completed the reversal stage successfully. Task performance in chronic users of amphetamines and opiates, as well as in former drug users, was not measurably impaired.
Conclusion
Our findings provide convincing evidence for response perseveration in cocaine users during probabilistic reversal-learning. Pharmacological differences between amphetamine and cocaine, in particular their respective effects on the 5-HT system, may account for the divergent task performance between the two psychostimulant user groups. The inability to reverse responses according to changes in reinforcement contingencies may underlie the maladaptive behaviour patterns observed in chronic cocaine users but not in chronic users of amphetamines or opiates. |
---|---|
AbstractList | Rationale
Chronic drug use has been associated with increased impulsivity and maladaptive behaviour, but the underlying mechanisms of this impairment remain unclear. We investigated the ability to adapt behaviour according to changes in reward contingencies, using a probabilistic reversal-learning task, in chronic drug users and controls.
Materials and methods
Five groups were compared: chronic amphetamine users (
n
= 30); chronic cocaine users (
n
= 27); chronic opiate users (
n
= 42); former drug users of psychostimulants and opiates (
n
= 26); and healthy non-drug-taking control volunteers (
n
= 25). Participants had to make a forced choice between two alternative stimuli on each trial to acquire a stimulus–reward association on the basis of degraded feedback and subsequently to reverse their responses when the reward contingencies changed.
Results
Chronic cocaine users demonstrated little behavioural change in response to the change in reward contingencies, as reflected by perseverative responding to the previously rewarded stimulus. Perseverative responding was observed in cocaine users regardless of whether they completed the reversal stage successfully. Task performance in chronic users of amphetamines and opiates, as well as in former drug users, was not measurably impaired.
Conclusion
Our findings provide convincing evidence for response perseveration in cocaine users during probabilistic reversal-learning. Pharmacological differences between amphetamine and cocaine, in particular their respective effects on the 5-HT system, may account for the divergent task performance between the two psychostimulant user groups. The inability to reverse responses according to changes in reinforcement contingencies may underlie the maladaptive behaviour patterns observed in chronic cocaine users but not in chronic users of amphetamines or opiates. Chronic drug use has been associated with increased impulsivity and maladaptive behaviour, but the underlying mechanisms of this impairment remain unclear. We investigated the ability to adapt behaviour according to changes in reward contingencies, using a probabilistic reversal-learning task, in chronic drug users and controls. Five groups were compared: chronic amphetamine users (n = 30); chronic cocaine users (n = 27); chronic opiate users (n = 42); former drug users of psychostimulants and opiates (n = 26); and healthy non-drug-taking control volunteers (n = 25). Participants had to make a forced choice between two alternative stimuli on each trial to acquire a stimulus-reward association on the basis of degraded feedback and subsequently to reverse their responses when the reward contingencies changed. Chronic cocaine users demonstrated little behavioural change in response to the change in reward contingencies, as reflected by perseverative responding to the previously rewarded stimulus. Perseverative responding was observed in cocaine users regardless of whether they completed the reversal stage successfully. Task performance in chronic users of amphetamines and opiates, as well as in former drug users, was not measurably impaired. Our findings provide convincing evidence for response perseveration in cocaine users during probabilistic reversal-learning. Pharmacological differences between amphetamine and cocaine, in particular their respective effects on the 5-HT system, may account for the divergent task performance between the two psychostimulant user groups. The inability to reverse responses according to changes in reinforcement contingencies may underlie the maladaptive behaviour patterns observed in chronic cocaine users but not in chronic users of amphetamines or opiates. Chronic drug use has been associated with increased impulsivity and maladaptive behaviour, but the underlying mechanisms of this impairment remain unclear. We investigated the ability to adapt behaviour according to changes in reward contingencies, using a probabilistic reversal-learning task, in chronic drug users and controls.RATIONALEChronic drug use has been associated with increased impulsivity and maladaptive behaviour, but the underlying mechanisms of this impairment remain unclear. We investigated the ability to adapt behaviour according to changes in reward contingencies, using a probabilistic reversal-learning task, in chronic drug users and controls.Five groups were compared: chronic amphetamine users (n = 30); chronic cocaine users (n = 27); chronic opiate users (n = 42); former drug users of psychostimulants and opiates (n = 26); and healthy non-drug-taking control volunteers (n = 25). Participants had to make a forced choice between two alternative stimuli on each trial to acquire a stimulus-reward association on the basis of degraded feedback and subsequently to reverse their responses when the reward contingencies changed.MATERIALS AND METHODSFive groups were compared: chronic amphetamine users (n = 30); chronic cocaine users (n = 27); chronic opiate users (n = 42); former drug users of psychostimulants and opiates (n = 26); and healthy non-drug-taking control volunteers (n = 25). Participants had to make a forced choice between two alternative stimuli on each trial to acquire a stimulus-reward association on the basis of degraded feedback and subsequently to reverse their responses when the reward contingencies changed.Chronic cocaine users demonstrated little behavioural change in response to the change in reward contingencies, as reflected by perseverative responding to the previously rewarded stimulus. Perseverative responding was observed in cocaine users regardless of whether they completed the reversal stage successfully. Task performance in chronic users of amphetamines and opiates, as well as in former drug users, was not measurably impaired.RESULTSChronic cocaine users demonstrated little behavioural change in response to the change in reward contingencies, as reflected by perseverative responding to the previously rewarded stimulus. Perseverative responding was observed in cocaine users regardless of whether they completed the reversal stage successfully. Task performance in chronic users of amphetamines and opiates, as well as in former drug users, was not measurably impaired.Our findings provide convincing evidence for response perseveration in cocaine users during probabilistic reversal-learning. Pharmacological differences between amphetamine and cocaine, in particular their respective effects on the 5-HT system, may account for the divergent task performance between the two psychostimulant user groups. The inability to reverse responses according to changes in reinforcement contingencies may underlie the maladaptive behaviour patterns observed in chronic cocaine users but not in chronic users of amphetamines or opiates.CONCLUSIONOur findings provide convincing evidence for response perseveration in cocaine users during probabilistic reversal-learning. Pharmacological differences between amphetamine and cocaine, in particular their respective effects on the 5-HT system, may account for the divergent task performance between the two psychostimulant user groups. The inability to reverse responses according to changes in reinforcement contingencies may underlie the maladaptive behaviour patterns observed in chronic cocaine users but not in chronic users of amphetamines or opiates. Rationale: Chronic drug use has been associated with increased impulsivity and maladaptive behaviour, but the underlying mechanisms of this impairment remain unclear. We investigated the ability to adapt behaviour according to changes in reward contingencies, using a probabilistic reversal-learning task, in chronic drug users and controls. Materials and methods: Five groups were compared: chronic amphetamine users (n = 30); chronic cocaine users (n = 27); chronic opiate users (n = 42); former drug users of psychostimulants and opiates (n = 26); and healthy non-drug-taking control volunteers (n = 25). Participants had to make a forced choice between two alternative stimuli on each trial to acquire a stimulus-reward association on the basis of degraded feedback and subsequently to reverse their responses when the reward contingencies changed. Results: Chronic cocaine users demonstrated little behavioural change in response to the change in reward contingencies, as reflected by perseverative responding to the previously rewarded stimulus. Perseverative responding was observed in cocaine users regardless of whether they completed the reversal stage successfully. Task performance in chronic users of amphetamines and opiates, as well as in former drug users, was not measurably impaired. Conclusion: Our findings provide convincing evidence for response perseveration in cocaine users during probabilistic reversal-learning. Pharmacological differences between amphetamine and cocaine, in particular their respective effects on the 5-HT system, may account for the divergent task performance between the two psychostimulant user groups. The inability to reverse responses according to changes in reinforcement contingencies may underlie the maladaptive behaviour patterns observed in chronic cocaine users but not in chronic users of amphetamines or opiates. Chronic drug use has been associated with increased impulsivity and maladaptive behaviour, but the underlying mechanisms of this impairment remain unclear. We investigated the ability to adapt behaviour according to changes in reward contingencies, using a probabilistic reversal-learning task, in chronic drug users and controls. Five groups were compared: chronic amphetamine users (n = 30); chronic cocaine users (n = 27); chronic opiate users (n = 42); former drug users of psychostimulants and opiates (n = 26); and healthy non-drug-taking control volunteers (n = 25). Participants had to make a forced choice between two alternative stimuli on each trial to acquire a stimulus-reward association on the basis of degraded feedback and subsequently to reverse their responses when the reward contingencies changed. Chronic cocaine users demonstrated little behavioural change in response to the change in reward contingencies, as reflected by perseverative responding to the previously rewarded stimulus. Perseverative responding was observed in cocaine users regardless of whether they completed the reversal stage successfully. Task performance in chronic users of amphetamines and opiates, as well as in former drug users, was not measurably impaired. Our findings provide convincing evidence for response perseveration in cocaine users during probabilistic reversal-learning. Pharmacological differences between amphetamine and cocaine, in particular their respective effects on the 5-HT system, may account for the divergent task performance between the two psychostimulant user groups. The inability to reverse responses according to changes in reinforcement contingencies may underlie the maladaptive behaviour patterns observed in chronic cocaine users but not in chronic users of amphetamines or opiates. [PUBLICATION ABSTRACT] |
Author | Robbins, Trevor W. Roiser, Jonathan P. Sahakian, Barbara J. Ersche, Karen D. |
Author_xml | – sequence: 1 givenname: Karen D. surname: Ersche fullname: Ersche, Karen D. email: ke220@cam.ac.uk organization: Department of Psychiatry, Brain Mapping Unit, School of Clinical Medicine, University of Cambridge, Behavioural and Clinical Neurosciences Institute, University of Cambridge – sequence: 2 givenname: Jonathan P. surname: Roiser fullname: Roiser, Jonathan P. organization: Behavioural and Clinical Neurosciences Institute, University of Cambridge, Department of Psychiatry, School of Clinical Medicine, University of Cambridge, Institute of Cognitive Neuroscience – sequence: 3 givenname: Trevor W. surname: Robbins fullname: Robbins, Trevor W. organization: Behavioural and Clinical Neurosciences Institute, University of Cambridge, Department of Experimental Psychology, University of Cambridge – sequence: 4 givenname: Barbara J. surname: Sahakian fullname: Sahakian, Barbara J. organization: Behavioural and Clinical Neurosciences Institute, University of Cambridge, Department of Psychiatry, School of Clinical Medicine, University of Cambridge |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20233315$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/18214445$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkkuLFDEQx4OsuLOrH8CLBEFvrXl2Zy-CDL5gwYueQyZdmc7SnbRJesRvb5oZd3VBzSVF6lf_1OsCnYUYAKGnlLyihHSvMyGM8qaaDSWSNvQB2lDBWcNIx87QhhDOG06lOkcXOd-QeoQSj9A5VYwKIeQGwXZIMXiLbbTGB8C7peAQC7andzPNAxQzrb4lA_YZm5yj9aZAj7_7MuAZUoYDJFP8AXCCPMfQ-7DHPuBhmUzIj9FDZ8YMT073Jfr6_t2X7cfm-vOHT9u3140VSpbGWCeoYxQk9M4pYahtoTdcCRCSCbDWsSvp-p0jPbMdJ6yzpu0J6SljHBy_RG-OuvOym6C3EEoyo56Tn0z6oaPx-k9P8IPex4PmnZKU0yrw8iSQ4rcFctGTzxbG0QSIS9atkm3LBPkvyEhLOBFdBZ_fA2_ikkLtgmZUXUlVZ1GhZ7_nfZvwrzlV4MUJMNma0SUTrM-3HCOM8zroytEjZ1PMOYG7kyJ63Rl93Bm9muvO6LXm7l6M9aXOMq4t8uM_I9kxMtdfwh7SXW1_D_oJTnnW-Q |
CODEN | PSYPAG |
CitedBy_id | crossref_primary_10_1007_s00213_011_2550_7 crossref_primary_10_1016_j_biopsych_2020_06_020 crossref_primary_10_1038_npp_2009_127 crossref_primary_10_1111_nyas_12388 crossref_primary_10_3389_fpsyt_2016_00034 crossref_primary_10_1016_j_nlm_2016_01_017 crossref_primary_10_1111_j_1369_1600_2011_00351_x crossref_primary_10_1007_s00213_018_4922_8 crossref_primary_10_1111_ejn_12644 crossref_primary_10_1016_j_drugalcdep_2013_09_029 crossref_primary_10_1038_s41398_019_0445_2 crossref_primary_10_1196_annals_1441_030 crossref_primary_10_1523_JNEUROSCI_0029_12_2012 crossref_primary_10_1016_j_pnpbp_2017_02_024 crossref_primary_10_1038_s41386_021_01136_w crossref_primary_10_1080_10826084_2016_1178293 crossref_primary_10_1111_j_1460_9568_2012_08000_x crossref_primary_10_1111_tra_12295 crossref_primary_10_1016_j_neubiorev_2018_11_015 crossref_primary_10_1111_j_1369_1600_2008_00134_x crossref_primary_10_1016_j_drugalcdep_2011_09_025 crossref_primary_10_1007_s00213_010_1833_8 crossref_primary_10_1016_j_biopsych_2011_01_014 crossref_primary_10_1002_brb3_65 crossref_primary_10_1093_cercor_bhac459 crossref_primary_10_1002_cpmo_82 crossref_primary_10_1007_s00213_017_4689_3 crossref_primary_10_1016_j_neuropharm_2011_04_007 crossref_primary_10_1111_j_1369_1600_2009_00200_x crossref_primary_10_1093_cercor_bhaa277 crossref_primary_10_1523_JNEUROSCI_1440_13_2013 crossref_primary_10_1017_S0140525X20000357 crossref_primary_10_1007_s00213_014_3534_1 crossref_primary_10_1016_j_biopsych_2020_02_017 crossref_primary_10_1016_j_bbr_2013_12_025 crossref_primary_10_1098_rstb_2008_0102 crossref_primary_10_1016_j_pbb_2020_172994 crossref_primary_10_1177_2043808718779431 crossref_primary_10_1192_bjp_bp_114_152223 crossref_primary_10_1016_j_bpsgos_2023_06_001 crossref_primary_10_1038_s41386_020_0600_8 crossref_primary_10_1016_j_neuropharm_2013_06_031 crossref_primary_10_1196_annals_1441_020 crossref_primary_10_1016_j_bbr_2012_09_005 crossref_primary_10_1177_0269881120926674 crossref_primary_10_1016_j_ddmod_2009_03_011 crossref_primary_10_1016_j_biopsych_2014_11_017 crossref_primary_10_1523_JNEUROSCI_1755_20_2020 crossref_primary_10_1016_j_biopsych_2012_08_018 crossref_primary_10_1038_npp_2016_147 crossref_primary_10_1101_lm_036251_114 crossref_primary_10_1016_j_pscychresns_2012_01_006 crossref_primary_10_1016_j_biopsych_2018_12_017 crossref_primary_10_1523_JNEUROSCI_2777_14_2015 crossref_primary_10_3109_00952990_2014_939752 crossref_primary_10_3389_fpsyt_2023_1170541 crossref_primary_10_1016_j_bbr_2020_112815 crossref_primary_10_3758_s13415_023_01139_8 crossref_primary_10_1038_s41386_022_01514_y crossref_primary_10_3389_fnhum_2015_00343 crossref_primary_10_1002_da_20897 crossref_primary_10_1016_j_drugalcdep_2015_03_021 crossref_primary_10_1016_j_pbb_2010_04_012 crossref_primary_10_1016_j_psychres_2009_11_024 crossref_primary_10_1097_FBP_0000000000000771 crossref_primary_10_1007_s00213_011_2485_z crossref_primary_10_1162_jocn_a_01784 crossref_primary_10_1016_j_peptides_2009_09_027 crossref_primary_10_1007_s00213_014_3598_y crossref_primary_10_1007_s00213_019_05325_w crossref_primary_10_1016_j_euroneuro_2015_12_003 crossref_primary_10_1177_1073191116654218 crossref_primary_10_1016_j_neuropsychologia_2011_02_023 crossref_primary_10_1016_j_biopsych_2012_12_002 crossref_primary_10_1016_j_jsat_2021_108291 crossref_primary_10_1093_cercor_bhy276 crossref_primary_10_1007_s00213_013_3135_4 crossref_primary_10_1016_j_drugalcdep_2019_107610 crossref_primary_10_1038_npp_2017_159 crossref_primary_10_1016_j_pbb_2009_05_013 crossref_primary_10_1016_j_cortex_2021_07_002 crossref_primary_10_3389_fpsyt_2020_588768 crossref_primary_10_1080_00952990_2017_1355919 crossref_primary_10_1016_j_neubiorev_2012_04_006 crossref_primary_10_3389_fnbeh_2016_00154 crossref_primary_10_1016_j_neubiorev_2016_04_006 crossref_primary_10_1038_npp_2009_48 crossref_primary_10_1093_ijnp_pyad019 crossref_primary_10_1007_s40473_016_0068_3 crossref_primary_10_1016_j_biopsych_2020_08_008 crossref_primary_10_1007_s00213_009_1558_8 crossref_primary_10_1523_JNEUROSCI_2219_18_2018 crossref_primary_10_1038_nn_3014 crossref_primary_10_1177_0269881109349841 crossref_primary_10_1016_j_neuropharm_2012_07_025 crossref_primary_10_1007_s00213_012_2689_x crossref_primary_10_1097_FBP_0b013e3283305eb4 crossref_primary_10_1016_j_cobeha_2024_101402 crossref_primary_10_1038_npp_2012_6 crossref_primary_10_1097_FBP_0b013e328333a2bb crossref_primary_10_3724_SP_J_1042_2021_01345 crossref_primary_10_1017_S1092852914000133 crossref_primary_10_3389_fpsyt_2022_960238 crossref_primary_10_1007_s00213_013_3390_4 crossref_primary_10_1007_s00213_011_2579_7 crossref_primary_10_1016_j_nicl_2017_04_010 crossref_primary_10_1111_ejn_12289 crossref_primary_10_1016_j_neubiorev_2010_04_008 crossref_primary_10_1016_j_cub_2024_09_064 crossref_primary_10_1016_j_neuropharm_2013_05_022 crossref_primary_10_1016_j_ejphar_2009_10_019 crossref_primary_10_1016_j_semcdb_2009_01_002 crossref_primary_10_1016_j_neuropharm_2008_07_019 crossref_primary_10_1093_ijnp_pyab041 crossref_primary_10_1159_000362840 crossref_primary_10_1016_j_drugalcdep_2010_11_030 crossref_primary_10_1007_s00213_008_1182_z crossref_primary_10_1007_s00213_015_4141_5 crossref_primary_10_1016_j_pneurobio_2013_06_005 crossref_primary_10_1016_j_biopsych_2011_06_033 crossref_primary_10_1038_npp_2010_165 crossref_primary_10_1038_npp_2012_111 crossref_primary_10_1007_s00213_015_3865_6 crossref_primary_10_1016_j_neubiorev_2013_02_010 crossref_primary_10_1016_j_neubiorev_2015_04_009 crossref_primary_10_1016_j_pbb_2008_08_006 crossref_primary_10_1016_j_conb_2013_05_001 crossref_primary_10_1007_s11920_011_0224_0 crossref_primary_10_1093_cercor_bhw312 crossref_primary_10_1162_jocn_a_01011 crossref_primary_10_1038_s41386_019_0381_0 crossref_primary_10_1007_s00213_022_06174_w crossref_primary_10_1523_JNEUROSCI_3765_09_2009 crossref_primary_10_1016_j_neuropharm_2013_05_033 crossref_primary_10_3758_s13415_018_0638_9 crossref_primary_10_1016_j_pnpbp_2018_01_010 crossref_primary_10_3389_fnbeh_2017_00237 crossref_primary_10_1523_JNEUROSCI_2730_11_2012 crossref_primary_10_1016_j_medcli_2008_07_019 crossref_primary_10_1002_mds_22836 crossref_primary_10_1186_s40359_020_00482_6 crossref_primary_10_1016_j_neubiorev_2013_07_003 crossref_primary_10_1016_j_neuropharm_2014_06_003 crossref_primary_10_3758_s13420_017_0274_1 crossref_primary_10_1523_JNEUROSCI_5066_10_2011 crossref_primary_10_1097_ADM_0000000000000066 crossref_primary_10_1146_annurev_psych_122414_033457 crossref_primary_10_1152_jn_00180_2020 crossref_primary_10_3389_fpsyt_2023_1208120 crossref_primary_10_1007_s00213_011_2181_z crossref_primary_10_1007_s00213_011_2372_7 crossref_primary_10_1111_acer_12393 crossref_primary_10_1111_j_1530_0277_2011_01668_x crossref_primary_10_1162_CPSY_a_00002 crossref_primary_10_1523_JNEUROSCI_5426_10_2011 crossref_primary_10_3758_s13428_021_01739_7 crossref_primary_10_1038_npp_2009_142 crossref_primary_10_1038_nrn3104 crossref_primary_10_1016_j_drugalcdep_2018_08_008 crossref_primary_10_1016_j_biopsych_2008_12_008 crossref_primary_10_1098_rstb_2008_0089 crossref_primary_10_1016_j_neubiorev_2015_06_015 crossref_primary_10_1111_ejn_13961 crossref_primary_10_1038_s41386_022_01387_1 crossref_primary_10_1016_j_biopsych_2012_05_001 crossref_primary_10_1016_j_neubiorev_2008_08_008 crossref_primary_10_1016_j_bbr_2012_03_005 crossref_primary_10_1016_j_biopsych_2011_01_008 crossref_primary_10_1038_npp_2014_335 crossref_primary_10_1016_j_addbeh_2020_106534 crossref_primary_10_1007_s00213_012_2746_5 crossref_primary_10_1007_s00213_019_05330_z crossref_primary_10_1111_j_1749_6632_2010_05899_x crossref_primary_10_1093_brain_awac366 crossref_primary_10_1111_adb_12143 crossref_primary_10_1016_j_neubiorev_2017_05_019 crossref_primary_10_1111_nyas_14929 |
Cites_doi | 10.1001/archpsyc.61.1.73 10.1177/0269881105057000 10.1016/S0893-133X(01)00355-4 10.1007/s002130100911 10.1038/sj.npp.1301337 10.1126/science.3155875 10.1017/S0033291702007018 10.1016/j.addbeh.2004.04.015 10.1001/archpsyc.63.1.90 10.1073/pnas.85.14.5274 10.1136/jnnp.57.12.1518 10.1016/0014-2999(85)90179-7 10.1016/j.addbeh.2004.10.010 10.1016/0028-3908(83)90075-8 10.1016/j.drugalcdep.2005.02.002 10.1038/sj.npp.1301225 10.1146/annurev.pa.33.040193.003231 10.1093/cercor/10.3.326 10.1046/j.1471-4159.1997.68052032.x 10.1126/science.1121218 10.1111/j.1360-0443.2005.01160.x 10.1016/j.neulet.2005.03.053 10.1126/science.1094987 10.1007/s00213-005-0104-6 10.1162/089892904322926791 10.1038/sj.npp.1300663 10.1007/PL00005483 10.1016/S0893-6080(02)00052-7 10.1111/j.1460-9568.2004.03274.x 10.1016/0091-3057(81)90401-9 10.1016/S0376-8716(98)00072-6 10.1016/j.biopsych.2003.09.011 10.1038/sj.npp.1300247 10.2165/00003088-200443030-00002 10.1016/S0893-133X(00)00097-X 10.1523/JNEUROSCI.3321-04.2004 10.1080/09595230600657758 10.1016/S0028-3932(99)00035-4 10.1016/0740-5472(92)90062-S 10.1093/cercor/10.3.284 10.1016/S1364-6613(98)01240-6 10.1016/S0028-3932(99)00103-7 10.1111/j.1360-0443.1995.tb02199.x 10.1038/nn1579 10.1016/S0376-8716(01)00206-X 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1 10.1111/j.1360-0443.2006.01314.x 10.1126/science.275.5306.1593 10.1007/BF00439267 10.1016/j.pnpbp.2007.08.040 10.1016/j.addbeh.2006.06.032 10.1523/JNEUROSCI.15-02-01308.1995 10.1136/jnnp.58.5.598 10.1523/JNEUROSCI.23-21-07839.2003 10.18356/58c4f2e4-en 10.1046/j.1360-0443.1995.9056072.x 10.1523/JNEUROSCI.16-03-01230.1996 10.1523/JNEUROSCI.22-11-04563.2002 |
ContentType | Journal Article |
Copyright | Springer-Verlag 2007 2008 INIST-CNRS Springer-Verlag 2008 Springer-Verlag 2007 2007 |
Copyright_xml | – notice: Springer-Verlag 2007 – notice: 2008 INIST-CNRS – notice: Springer-Verlag 2008 – notice: Springer-Verlag 2007 2007 |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 3V. 7QG 7QR 7RV 7TK 7X7 7XB 88E 88G 8AO 8FD 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ K9. KB0 M0S M1P M2M NAPCQ P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 5PM |
DOI | 10.1007/s00213-007-1051-1 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Animal Behavior Abstracts Chemoreception Abstracts Nursing & Allied Health Database Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Pharma Collection Technology Research Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Databases ProQuest One Community College ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection Medical Database Psychology Collection Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Psychology ProQuest Central Student Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection Chemoreception Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition Animal Behavior Abstracts ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic Neurosciences Abstracts ProQuest One Psychology |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1432-2072 |
EndPage | 431 |
ExternalDocumentID | PMC3785131 1456226621 18214445 20233315 10_1007_s00213_007_1051_1 |
Genre | Research Support, Non-U.S. Gov't Journal Article Comparative Study |
GrantInformation_xml | – fundername: Wellcome Trust grantid: 076274 – fundername: Medical Research Council grantid: G0001354 – fundername: Wellcome Trust grantid: 076274/Z/04/Z – fundername: Wellcome Trust : grantid: 076274 || WT |
GroupedDBID | -4W -BR .55 3SX 40D 40E 95. 95~ ABMNI AGWIL ALMA_UNASSIGNED_HOLDINGS KOW N2Q R9- RHV SBY SOJ X7M ~EX AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 3V. 7QG 7QR 7RV 7TK 7X7 7XB 88E 8AO 8FD 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FR3 FYUFA GNUQQ K9. M1P M2M NAPCQ P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 5PM |
ID | FETCH-LOGICAL-c485t-acf41f21e5edff84a1c6eda384e4524eccf295fdbf0d2c73027ca6d00d1223ef3 |
IEDL.DBID | U2A |
ISSN | 0033-3158 |
IngestDate | Thu Aug 21 17:55:41 EDT 2025 Fri Jul 11 09:32:58 EDT 2025 Fri Jul 11 12:03:16 EDT 2025 Sat Aug 16 22:50:40 EDT 2025 Fri May 30 11:01:11 EDT 2025 Tue Sep 20 21:42:20 EDT 2022 Thu Apr 24 22:51:56 EDT 2025 Tue Jul 01 04:16:32 EDT 2025 Fri Feb 21 02:34:17 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Amphetamines Opiates Perseveration Cocaine Probabilistic reversal learning Serotonin Amphetamine derivatives Human CNS stimulant Psychotropic Ester Chronic Probabilistic reversal learning, Serotonin Reversal learning Neurotransmitter Amfetamine Probability learning Drug of abuse |
Language | English |
License | http://www.springer.com/tdm CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c485t-acf41f21e5edff84a1c6eda384e4524eccf295fdbf0d2c73027ca6d00d1223ef3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 |
PMID | 18214445 |
PQID | 218958182 |
PQPubID | 47309 |
PageCount | 11 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3785131 proquest_miscellaneous_68566240 proquest_miscellaneous_20603047 proquest_journals_218958182 pubmed_primary_18214445 pascalfrancis_primary_20233315 crossref_primary_10_1007_s00213_007_1051_1 crossref_citationtrail_10_1007_s00213_007_1051_1 springer_journals_10_1007_s00213_007_1051_1 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2008-04-01 |
PublicationDateYYYYMMDD | 2008-04-01 |
PublicationDate_xml | – month: 04 year: 2008 text: 2008-04-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Berlin/Heidelberg |
PublicationPlace_xml | – name: Berlin/Heidelberg – name: Berlin – name: Germany – name: Heidelberg |
PublicationTitle | Psychopharmacologia |
PublicationTitleAbbrev | Psychopharmacology |
PublicationTitleAlternate | Psychopharmacology (Berl) |
PublicationYear | 2008 |
Publisher | Springer-Verlag Springer Springer Nature B.V |
Publisher_xml | – name: Springer-Verlag – name: Springer – name: Springer Nature B.V |
References | Daw, Kakade, Dayan (CR9) 2002; 15 Evers, Cools, Clark, van der Veen, Jolles, Sahakian, Robbins (CR14) 2005; 30 McGregor, Srisurapanont, Jittiwutikarn, Laobhripatr, Wongtan, White (CR39) 2005; 100 Kuczenski, Segal, Cho, Melega (CR31) 1995; 15 Segal, Kuczenski, O’Neil, Melega, Cho (CR57) 2003; 28 Clarke, Dalley, Crofts, Robbins, Roberts (CR7) 2004; 304 Fillmore, Rush (CR17) 2006; 20 Swainson, Rogers, Sahakian, Summers, Polkey, Robbins (CR61) 2000; 38 Verdejo-Garcia, Perales, Perez-Garcia (CR65) 2007; 32 Arnsten (CR2) 1998; 2 Howell, Hoffman, Votaw, Landrum, Wilcox, Lindsey (CR26) 2002; 159 Rolls, Hornak, Wade, Mcgrath (CR54) 1994; 57 Annett, Ridley, Gamble, Baker (CR1) 1983; 81 London, Simon, Berman, Mandelkern, Lichtman, Bramen, Shinn, Miotto, Learn, Dong, Matochik, Kurian, Newton, Woods, Rawson, Ling (CR36) 2004; 61 Forman, Dougherty, Casey, Siegle, Braver, Barch, Stenger, Wick-Hull, Pisarov, Lorensen (CR18) 2004; 55 (CR62) 1999 Clark, Roiser, Cools, Rubinsztein, Sahakian, Robbins (CR6) 2005; 182 De Win, Reneman, Jager, Vlieger, Olabarriaga, Lavini, Bisschops, Majoie, Booij, den Heeten, Van den Brink (CR11) 2007; 32 Beck, Steer, Brown (CR3) 1996 Schoenbaum, Saddoris, Ramus, Shaham, Setlow (CR55) 2004; 19 de la Torre, Farre, Navarro, Pacifici, Zuccaro, Pichini (CR10) 2004; 43 Filip, Frankowska, Zaniewska, Golda, Przegalinski (CR15) 2005; 57 Fillmore, Rush (CR16) 2002; 66 Schultz, Dayan, Montague (CR56) 1997; 275 Hester, Garavan (CR23) 2004; 24 Jentsch, Taylor (CR27) 1999; 146 Lee, Zhou, Luo, Yuen, Ruan, Weng (CR35) 2005; 382 Howell (CR25) 1997 Johanson, Fischman (CR29) 1989; 41 Lange, Sahakian, Quinn, Marsden, Robbins (CR5) 1995; 8 McLellan, Kushner, Metzger, Peters, Smith, Grissom, Pettinati, Argeriou (CR40) 1992; 9 Ridley, Haystead, Baker (CR51) 1981; 14 Lawrence, Sahakian, Rogers, Hodges, Robbins (CR33) 1999; 37 Porrino, Smith, Nader, Beveridge (CR49) 2007; 31 Cools, Clark, Owen, Robbins (CR8) 2002; 22 Kaufman, Ross, Stein, Garavan (CR30) 2003; 23 CR19 Lee, Groman, London, Jentsch (CR34) 2007; 32 Sekine, Ouchi, Takei, Yoshikawa, Nakamura, Futatsubashi, Okada, Minabe, Suzuki, Iwata, Tsuchiya, Tsukada, Iyo, Mori (CR59) 2006; 63 Verdejo-Garcia, Lopez-Torrecillas, Aguilar de Arcos, Perez-Garcia (CR64) 2005; 30 Everitt, Robbins (CR13) 2005; 8 Jentsch, Olausson, De La Garza, Taylor (CR28) 2002; 26 Gouzoulis-Mayfrank, Daumann (CR21) 2006; 101 White, Kalivas (CR66) 1998; 51 Rolls (CR53) 2000; 10 Seiden, Sabol, Ricaurte (CR58) 1993; 33 Lyvers (CR38) 2006; 25 Nelson (CR43) 1982 Ridley, Haystead, Baker (CR52) 1981; 14 Kuczenski, Segal (CR32) 1997; 68 Ricaurte, Fuller, Perry, Seiden, Schuster (CR50) 1983; 22 Graveland, Williams, Difiglia (CR22) 1985; 227 Hornak, O’Doherty, Bramham, Rolls, Morris, Bullock, Polkey (CR24) 2004; 16 Peltier, Li, Lytle, Taylor, Emmett-Oglesby (CR47) 1996; 277 Chamberlain, Muller, Blackwell, Clark, Robbins, Sahakian (CR4) 2006; 311 Di Chiara, Imperato (CR12) 1988; 85 Ornstein, Iddon, Baldacchino, Sahakian, London, Everitt, Robbins (CR44) 2000; 23 Peat, Warren, Bakhit, Gibb (CR46) 1985; 116 Murphy, Michael, Robbins, Sahakian (CR42) 2003; 33 Sofuoglu, Dudish-Poulsen, Poling, Mooney, Hatsukami (CR60) 2005; 30 Lyons, Friedman, Nader, Porrino (CR37) 1996; 16 Fillmore, Rush (CR67) 2006; 20 Gossop, Darke, Griffiths, Hando, Powis, Hall, Strang (CR20) 1995; 90 Monterosso, Aron, Cordova, Xu, London (CR41) 2005; 79 Porrino, Lyons (CR48) 2000; 10 (CR63) 2007 Patton, Stanford, Barratt (CR45) 1995; 51 DC Howell (1051_CR25) 1997 AJ Verdejo-Garcia (1051_CR65) 2007; 32 HE Nelson (1051_CR43) 1982 R Cools (1051_CR8) 2002; 22 E Gouzoulis-Mayfrank (1051_CR21) 2006; 101 GA Ricaurte (1051_CR50) 1983; 22 RM Ridley (1051_CR52) 1981; 14 DS Segal (1051_CR57) 2003; 28 CE Johanson (1051_CR29) 1989; 41 JH Patton (1051_CR45) 1995; 51 LJ Porrino (1051_CR49) 2007; 31 R Kuczenski (1051_CR32) 1997; 68 MT Fillmore (1051_CR16) 2002; 66 Y Sekine (1051_CR59) 2006; 63 AT Beck (1051_CR3) 1996 MA Peat (1051_CR46) 1985; 116 FJ White (1051_CR66) 1998; 51 M Lyvers (1051_CR38) 2006; 25 B Lee (1051_CR34) 2007; 32 C McGregor (1051_CR39) 2005; 100 D Lyons (1051_CR37) 1996; 16 LS Seiden (1051_CR58) 1993; 33 GA Graveland (1051_CR22) 1985; 227 LJ Porrino (1051_CR48) 2000; 10 J Hornak (1051_CR24) 2004; 16 AFT Arnsten (1051_CR2) 1998; 2 G Chiara Di (1051_CR12) 1988; 85 United Nations Office on Drugs and Crime (1051_CR63) 2007 EAT Evers (1051_CR14) 2005; 30 MT Fillmore (1051_CR17) 2006; 20 AD Lawrence (1051_CR33) 1999; 37 TJ Ornstein (1051_CR44) 2000; 23 R Hester (1051_CR23) 2004; 24 SD Forman (1051_CR18) 2004; 55 FC Murphy (1051_CR42) 2003; 33 W Schultz (1051_CR56) 1997; 275 MML Win De (1051_CR11) 2007; 32 TMC Lee (1051_CR35) 2005; 382 AT McLellan (1051_CR40) 1992; 9 R Swainson (1051_CR61) 2000; 38 1051_CR67 AJ Verdejo-Garcia (1051_CR64) 2005; 30 ED London (1051_CR36) 2004; 61 ET Rolls (1051_CR53) 2000; 10 RM Ridley (1051_CR51) 1981; 14 L Clark (1051_CR6) 2005; 182 ND Daw (1051_CR9) 2002; 15 M Filip (1051_CR15) 2005; 57 M Gossop (1051_CR20) 1995; 90 HF Clarke (1051_CR7) 2004; 304 R Torre de la (1051_CR10) 2004; 43 JD Jentsch (1051_CR28) 2002; 26 ET Rolls (1051_CR54) 1994; 57 JN Kaufman (1051_CR30) 2003; 23 M Sofuoglu (1051_CR60) 2005; 30 1051_CR19 SR Chamberlain (1051_CR4) 2006; 311 LE Annett (1051_CR1) 1983; 81 BJ Everitt (1051_CR13) 2005; 8 JR Monterosso (1051_CR41) 2005; 79 LL Howell (1051_CR26) 2002; 159 U.K.Department of Health (1051_CR62) 1999 1051_CR5 R Kuczenski (1051_CR31) 1995; 15 JD Jentsch (1051_CR27) 1999; 146 RL Peltier (1051_CR47) 1996; 277 G Schoenbaum (1051_CR55) 2004; 19 |
References_xml | – volume: 61 start-page: 73 year: 2004 end-page: 84 ident: CR36 article-title: Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.61.1.73 – volume: 20 start-page: 24 year: 2006 end-page: 32 ident: CR17 article-title: Polydrug abusers display impaired discrimination-reversal learning in a model of behavioural control publication-title: J Psychopharmacol doi: 10.1177/0269881105057000 – volume: 26 start-page: 183 year: 2002 end-page: 190 ident: CR28 article-title: Impairments of reversal learning and response perseveration after repeated, intermittent cocaine administrations to monkeys publication-title: Neuropsychopharmacology doi: 10.1016/S0893-133X(01)00355-4 – volume: 15 start-page: 1308 year: 1995 end-page: 1317 ident: CR31 article-title: Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine publication-title: J Neurosci – volume: 159 start-page: 154 year: 2002 end-page: 160 ident: CR26 article-title: Cocaine-induced brain activation determined by positron emission tomography neuroimaging in conscious rhesus monkeys publication-title: Psychopharmacology doi: 10.1007/s002130100911 – volume: 16 start-page: 1230 year: 1996 end-page: 1238 ident: CR37 article-title: Cocaine alters cerebral metabolism within the ventral striatum and limbic cortex of monkeys publication-title: J Neurosci – volume: 57 start-page: 685 year: 2005 end-page: 700 ident: CR15 article-title: The serotonergic system and its role in cocaine addiction publication-title: Pharmacol Rep – volume: 32 start-page: 2125 issue: 10 year: 2007 end-page: 2134 ident: CR34 article-title: Dopamine D2/D3 dopamine receptors play a specific role in reversal of a learned visual discrimination in monkeys publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1301337 – volume: 227 start-page: 770 year: 1985 end-page: 773 ident: CR22 article-title: Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntingtons-disease publication-title: Science doi: 10.1126/science.3155875 – volume: 33 start-page: 455 year: 2003 end-page: 467 ident: CR42 article-title: Neuropsychological impairment in patients with major depressive disorder: the effects of feedback on task performance publication-title: Psychol Med doi: 10.1017/S0033291702007018 – year: 2007 ident: CR63 publication-title: World drug report 2007 – volume: 30 start-page: 89 year: 2005 end-page: 101 ident: CR64 article-title: Differential effects of MDMA, cocaine, and cannabis use severity on distinctive components of the executive functions in polysubstance users: A multiple regression analysis publication-title: Addict Behav doi: 10.1016/j.addbeh.2004.04.015 – volume: 63 start-page: 90 year: 2006 end-page: 100 ident: CR59 article-title: Brain serotonin transporter density and aggression in abstinent methamphetamine abusers publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.63.1.90 – volume: 85 start-page: 5274 year: 1988 end-page: 5278 ident: CR12 article-title: Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.85.14.5274 – volume: 20 start-page: 24 year: 2006 end-page: 32 ident: CR67 article-title: Polydrug abusers display impaired discrimination-reversal learning in a model of behavioural control publication-title: J Psychopharmacol – volume: 57 start-page: 1518 year: 1994 end-page: 1524 ident: CR54 article-title: Emotion-related learning in patients with social and emotional changes associated with frontal-lobe damage publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp.57.12.1518 – year: 1996 ident: CR3 publication-title: Manual for Beck Depression Inventory-II – volume: 116 start-page: 11 year: 1985 end-page: 16 ident: CR46 article-title: The acute effects of methamphetamine, amphetamine and -chloroamphetamine on the cortical serotonergic system of the rat brain: evidence for differences in the effects of methamphetamine and amphetamine publication-title: Eur j pharmacol doi: 10.1016/0014-2999(85)90179-7 – volume: 30 start-page: 1125 year: 2005 end-page: 1134 ident: CR60 article-title: The effect of individual cocaine withdrawal symptoms on outcomes in cocaine users publication-title: Addict Behav doi: 10.1016/j.addbeh.2004.10.010 – volume: 22 start-page: 1165 year: 1983 end-page: 1169 ident: CR50 article-title: Fluoxetine increases long-lasting neostriatal dopamine depletion after administration of -methamphetamine and -amphetamine publication-title: Neuropharmacology doi: 10.1016/0028-3908(83)90075-8 – volume: 41 start-page: 3 year: 1989 end-page: 52 ident: CR29 article-title: The pharmacology of cocaine related to its abuse publication-title: Pharmacol Rev – ident: CR19 – volume: 79 start-page: 273 year: 2005 end-page: 277 ident: CR41 article-title: Deficits in response inhibition associated with chronic methamphetamine abuse publication-title: Drug Alcohol Depend doi: 10.1016/j.drugalcdep.2005.02.002 – volume: 32 start-page: 458 year: 2007 end-page: 470 ident: CR11 article-title: A prospective cohort study on sustained effects of low-dose ecstasy use on the brain in new ecstasy users publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1301225 – volume: 33 start-page: 639 year: 1993 end-page: 676 ident: CR58 article-title: Amphetamine: effects on catecholamine systems and behavior publication-title: Annu Rev Pharmacol Toxicol doi: 10.1146/annurev.pa.33.040193.003231 – volume: 10 start-page: 326 year: 2000 end-page: 333 ident: CR48 article-title: Orbital and medial prefrontal cortex and psychostimulant abuse: studies in animal models publication-title: Cereb Cortex doi: 10.1093/cercor/10.3.326 – year: 1997 ident: CR25 publication-title: Statistical methods for psychology – volume: 68 start-page: 2032 year: 1997 end-page: 2037 ident: CR32 article-title: Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine publication-title: J Neurochem doi: 10.1046/j.1471-4159.1997.68052032.x – volume: 311 start-page: 861 year: 2006 end-page: 863 ident: CR4 article-title: Neurochemical modulation of response inhibition and probabilistic learning in humans publication-title: Science doi: 10.1126/science.1121218 – volume: 100 start-page: 1320 year: 2005 end-page: 1329 ident: CR39 article-title: The nature, time course and severity of methamphetamine withdrawal publication-title: Addiction doi: 10.1111/j.1360-0443.2005.01160.x – volume: 22 start-page: 4563 year: 2002 end-page: 4567 ident: CR8 article-title: Defining the neural mechanisms of probabilistic reversal learning using event-related functional magnetic resonance imaging publication-title: J Neurosci – volume: 382 start-page: 211 year: 2005 end-page: 216 ident: CR35 article-title: Neural activity associated with cognitive regulation in heroin users: a fMRI study publication-title: Neurosci lett doi: 10.1016/j.neulet.2005.03.053 – volume: 8 start-page: 598 year: 1995 end-page: 606 ident: CR5 article-title: Comparison of executive and visuospatial memory function in Huntington’s disease and dementia of Alzheimer type matched for degree of dementia publication-title: J Neurol Neurosurg Psychiatry – volume: 304 start-page: 878 year: 2004 end-page: 880 ident: CR7 article-title: Cognitive inflexibility after prefrontal serotonin depletion publication-title: Science doi: 10.1126/science.1094987 – volume: 182 start-page: 570 year: 2005 end-page: 578 ident: CR6 article-title: Stop signal response inhibition is not modulated by tryptophan depletion or the serotonin transporter polymorphism in healthy volunteers: implications for the 5-HT theory of impulsivity publication-title: Psychopharmacology doi: 10.1007/s00213-005-0104-6 – volume: 16 start-page: 463 year: 2004 end-page: 478 ident: CR24 article-title: Reward-related reversal learning after surgical excisions in orbito-frontal or dorsolateral prefrontal cortex in humans publication-title: J cogn neurosci doi: 10.1162/089892904322926791 – volume: 30 start-page: 1138 year: 2005 end-page: 1147 ident: CR14 article-title: Serotonergic modulation of prefrontal cortex during negative feedback in probabilistic reversal learning publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1300663 – volume: 146 start-page: 373 year: 1999 end-page: 390 ident: CR27 article-title: Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli publication-title: Psychopharmacology doi: 10.1007/PL00005483 – volume: 23 start-page: 7839 year: 2003 end-page: 7843 ident: CR30 article-title: Cingulate hypoactivity in cocaine users during a GO–NOGO task as revealed by event-related functional magnetic resonance imaging publication-title: J Neurosci – volume: 15 start-page: 603 year: 2002 end-page: 616 ident: CR9 article-title: Opponent interactions between serotonin and dopamine publication-title: Neural netw doi: 10.1016/S0893-6080(02)00052-7 – volume: 19 start-page: 1997 year: 2004 end-page: 2002 ident: CR55 article-title: Cocaine-experienced rats exhibit learning deficits in a task sensitive to orbitofrontal cortex lesions publication-title: Eur J Neurosci doi: 10.1111/j.1460-9568.2004.03274.x – volume: 14 start-page: 345 year: 1981 end-page: 351 ident: CR52 article-title: An analysis of visual object reversal learning in the marmoset after amphetamine and haloperidol publication-title: Pharmacol Biochem Behav doi: 10.1016/0091-3057(81)90401-9 – volume: 51 start-page: 141 year: 1998 end-page: 153 ident: CR66 article-title: Neuroadaptations involved in amphetamine and cocaine addiction publication-title: Drug Alcohol Depend doi: 10.1016/S0376-8716(98)00072-6 – volume: 14 start-page: 345 year: 1981 end-page: 351 ident: CR51 article-title: An analysis of visual object reversal-learning in the marmoset after amphetamine and haloperidol publication-title: Pharmacol Biochem Behav doi: 10.1016/0091-3057(81)90401-9 – volume: 55 start-page: 531 year: 2004 end-page: 537 ident: CR18 article-title: Opiate addicts lack error-dependent activation of rostral anterior cingulate publication-title: Biol Psychiat doi: 10.1016/j.biopsych.2003.09.011 – volume: 28 start-page: 1730 year: 2003 end-page: 1740 ident: CR57 article-title: Escalating dose methamphetamine pretreatment alters the behavioral and neurochemical profiles associated with exposure to a high-dose methamphetamine binge publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1300247 – volume: 43 start-page: 157 year: 2004 end-page: 185 ident: CR10 article-title: Clinical pharmacokinetics of amfetamine and related substances—monitoring in conventional and non-conventional matrices publication-title: Clin pharmacokinet doi: 10.2165/00003088-200443030-00002 – volume: 277 start-page: 212 year: 1996 end-page: 218 ident: CR47 article-title: Chronic -amphetamine or methamphetamine produces cross-tolerance to the discriminative and reinforcing stimulus effects of cocaine publication-title: J Pharmacol Exp Ther – volume: 23 start-page: 113 year: 2000 end-page: 126 ident: CR44 article-title: Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers publication-title: Neuropsychopharmacology doi: 10.1016/S0893-133X(00)00097-X – volume: 24 start-page: 11017 year: 2004 end-page: 11022 ident: CR23 article-title: Executive dysfunction in cocaine addiction: evidence for discordant frontal, cingulate, and cerebellar activity publication-title: J Neurosci doi: 10.1523/JNEUROSCI.3321-04.2004 – volume: 25 start-page: 269 year: 2006 end-page: 276 ident: CR38 article-title: Recreational ecstasy use and the neurotoxic potential of MDMA: current status of the controversy and methodological issues publication-title: Drug Alcohol Rev doi: 10.1080/09595230600657758 – volume: 37 start-page: 1359 year: 1999 end-page: 1374 ident: CR33 article-title: Discrimination, reversal, and shift learning in Huntington’s disease: mechanisms of impaired response selection publication-title: Neuropsychologia doi: 10.1016/S0028-3932(99)00035-4 – volume: 9 start-page: 199 year: 1992 end-page: 213 ident: CR40 article-title: The fifth edition of the addiction severity index publication-title: J Subst Abuse Treat doi: 10.1016/0740-5472(92)90062-S – volume: 10 start-page: 284 year: 2000 end-page: 294 ident: CR53 article-title: The orbitofrontal cortex and reward publication-title: Cereb Cortex doi: 10.1093/cercor/10.3.284 – volume: 2 start-page: 436 year: 1998 end-page: 447 ident: CR2 article-title: Catecholamine modulation of prefrontal cortical cognitive function publication-title: Trends Cogn Sci doi: 10.1016/S1364-6613(98)01240-6 – volume: 38 start-page: 596 year: 2000 end-page: 612 ident: CR61 article-title: Probabilistic learning and reversal deficits in patients with Parkinson’s disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication publication-title: Neuropsychologia doi: 10.1016/S0028-3932(99)00103-7 – volume: 90 start-page: 607 year: 1995 end-page: 614 ident: CR20 article-title: The severity of dependence scale (SDS): Psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users publication-title: Addiction doi: 10.1111/j.1360-0443.1995.tb02199.x – volume: 8 start-page: 1481 year: 2005 end-page: 1489 ident: CR13 article-title: Neural systems of reinforcement for drug addiction: from actions to habits to compulsion publication-title: Nat Neurosci doi: 10.1038/nn1579 – volume: 66 start-page: 265 year: 2002 end-page: 273 ident: CR16 article-title: Impaired inhibitory control of behavior in chronic cocaine users publication-title: Drug Alcohol Depend doi: 10.1016/S0376-8716(01)00206-X – volume: 51 start-page: 768 year: 1995 end-page: 774 ident: CR45 article-title: Factor structure of the Barratt Impulsiveness Scale publication-title: J Clin Psychol doi: 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1 – year: 1982 ident: CR43 publication-title: National adult reading test manual – year: 1999 ident: CR62 publication-title: Drug misuse and dependence—guidelines on clinical management – volume: 101 start-page: 348 year: 2006 end-page: 361 ident: CR21 article-title: Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage publication-title: Addiction doi: 10.1111/j.1360-0443.2006.01314.x – volume: 275 start-page: 1593 year: 1997 end-page: 1599 ident: CR56 article-title: A neural substrate of prediction and reward publication-title: Science doi: 10.1126/science.275.5306.1593 – volume: 81 start-page: 18 year: 1983 end-page: 23 ident: CR1 article-title: Behavioral effects of intracerebral amphetamine in the marmoset publication-title: Psychopharmacology doi: 10.1007/BF00439267 – volume: 31 start-page: 1593 year: 2007 end-page: 1600 ident: CR49 article-title: The effects of cocaine: a shifting target over the course of addiction publication-title: Prog neuro-psychopharmacol biol psychiatry doi: 10.1016/j.pnpbp.2007.08.040 – volume: 32 start-page: 950 year: 2007 end-page: 966 ident: CR65 article-title: Cognitive impulsivity in cocaine and heroin polysubstance abusers publication-title: Addict Behav doi: 10.1016/j.addbeh.2006.06.032 – volume: 33 start-page: 455 year: 2003 ident: 1051_CR42 publication-title: Psychol Med doi: 10.1017/S0033291702007018 – volume: 15 start-page: 603 year: 2002 ident: 1051_CR9 publication-title: Neural netw doi: 10.1016/S0893-6080(02)00052-7 – volume: 55 start-page: 531 year: 2004 ident: 1051_CR18 publication-title: Biol Psychiat doi: 10.1016/j.biopsych.2003.09.011 – volume: 23 start-page: 113 year: 2000 ident: 1051_CR44 publication-title: Neuropsychopharmacology doi: 10.1016/S0893-133X(00)00097-X – volume: 24 start-page: 11017 year: 2004 ident: 1051_CR23 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.3321-04.2004 – volume: 28 start-page: 1730 year: 2003 ident: 1051_CR57 publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1300247 – volume-title: Drug misuse and dependence—guidelines on clinical management year: 1999 ident: 1051_CR62 – volume: 61 start-page: 73 year: 2004 ident: 1051_CR36 publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.61.1.73 – volume: 51 start-page: 768 year: 1995 ident: 1051_CR45 publication-title: J Clin Psychol doi: 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1 – volume: 15 start-page: 1308 year: 1995 ident: 1051_CR31 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.15-02-01308.1995 – volume: 33 start-page: 639 year: 1993 ident: 1051_CR58 publication-title: Annu Rev Pharmacol Toxicol doi: 10.1146/annurev.pa.33.040193.003231 – volume: 182 start-page: 570 year: 2005 ident: 1051_CR6 publication-title: Psychopharmacology doi: 10.1007/s00213-005-0104-6 – volume: 9 start-page: 199 year: 1992 ident: 1051_CR40 publication-title: J Subst Abuse Treat doi: 10.1016/0740-5472(92)90062-S – volume: 16 start-page: 463 year: 2004 ident: 1051_CR24 publication-title: J cogn neurosci doi: 10.1162/089892904322926791 – ident: 1051_CR5 doi: 10.1136/jnnp.58.5.598 – volume-title: Manual for Beck Depression Inventory-II year: 1996 ident: 1051_CR3 – volume: 23 start-page: 7839 year: 2003 ident: 1051_CR30 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.23-21-07839.2003 – volume: 22 start-page: 1165 year: 1983 ident: 1051_CR50 publication-title: Neuropharmacology doi: 10.1016/0028-3908(83)90075-8 – volume: 57 start-page: 685 year: 2005 ident: 1051_CR15 publication-title: Pharmacol Rep – volume: 10 start-page: 326 year: 2000 ident: 1051_CR48 publication-title: Cereb Cortex doi: 10.1093/cercor/10.3.326 – volume: 68 start-page: 2032 year: 1997 ident: 1051_CR32 publication-title: J Neurochem doi: 10.1046/j.1471-4159.1997.68052032.x – volume: 14 start-page: 345 year: 1981 ident: 1051_CR51 publication-title: Pharmacol Biochem Behav doi: 10.1016/0091-3057(81)90401-9 – volume: 8 start-page: 1481 year: 2005 ident: 1051_CR13 publication-title: Nat Neurosci doi: 10.1038/nn1579 – volume: 43 start-page: 157 year: 2004 ident: 1051_CR10 publication-title: Clin pharmacokinet doi: 10.2165/00003088-200443030-00002 – ident: 1051_CR19 – volume: 38 start-page: 596 year: 2000 ident: 1051_CR61 publication-title: Neuropsychologia doi: 10.1016/S0028-3932(99)00103-7 – volume: 2 start-page: 436 year: 1998 ident: 1051_CR2 publication-title: Trends Cogn Sci doi: 10.1016/S1364-6613(98)01240-6 – volume: 100 start-page: 1320 year: 2005 ident: 1051_CR39 publication-title: Addiction doi: 10.1111/j.1360-0443.2005.01160.x – volume: 63 start-page: 90 year: 2006 ident: 1051_CR59 publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.63.1.90 – volume: 37 start-page: 1359 year: 1999 ident: 1051_CR33 publication-title: Neuropsychologia doi: 10.1016/S0028-3932(99)00035-4 – volume: 30 start-page: 89 year: 2005 ident: 1051_CR64 publication-title: Addict Behav doi: 10.1016/j.addbeh.2004.04.015 – volume: 32 start-page: 458 year: 2007 ident: 1051_CR11 publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1301225 – volume: 19 start-page: 1997 year: 2004 ident: 1051_CR55 publication-title: Eur J Neurosci doi: 10.1111/j.1460-9568.2004.03274.x – volume: 32 start-page: 2125 issue: 10 year: 2007 ident: 1051_CR34 publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1301337 – volume: 85 start-page: 5274 year: 1988 ident: 1051_CR12 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.85.14.5274 – volume: 30 start-page: 1125 year: 2005 ident: 1051_CR60 publication-title: Addict Behav doi: 10.1016/j.addbeh.2004.10.010 – volume: 26 start-page: 183 year: 2002 ident: 1051_CR28 publication-title: Neuropsychopharmacology doi: 10.1016/S0893-133X(01)00355-4 – volume: 227 start-page: 770 year: 1985 ident: 1051_CR22 publication-title: Science doi: 10.1126/science.3155875 – ident: 1051_CR67 doi: 10.1177/0269881105057000 – volume: 304 start-page: 878 year: 2004 ident: 1051_CR7 publication-title: Science doi: 10.1126/science.1094987 – volume: 14 start-page: 345 year: 1981 ident: 1051_CR52 publication-title: Pharmacol Biochem Behav doi: 10.1016/0091-3057(81)90401-9 – volume: 79 start-page: 273 year: 2005 ident: 1051_CR41 publication-title: Drug Alcohol Depend doi: 10.1016/j.drugalcdep.2005.02.002 – volume-title: Statistical methods for psychology year: 1997 ident: 1051_CR25 – volume: 146 start-page: 373 year: 1999 ident: 1051_CR27 publication-title: Psychopharmacology doi: 10.1007/PL00005483 – volume: 25 start-page: 269 year: 2006 ident: 1051_CR38 publication-title: Drug Alcohol Rev doi: 10.1080/09595230600657758 – volume-title: National adult reading test manual year: 1982 ident: 1051_CR43 – volume: 41 start-page: 3 year: 1989 ident: 1051_CR29 publication-title: Pharmacol Rev – volume: 159 start-page: 154 year: 2002 ident: 1051_CR26 publication-title: Psychopharmacology doi: 10.1007/s002130100911 – volume: 277 start-page: 212 year: 1996 ident: 1051_CR47 publication-title: J Pharmacol Exp Ther – volume: 66 start-page: 265 year: 2002 ident: 1051_CR16 publication-title: Drug Alcohol Depend doi: 10.1016/S0376-8716(01)00206-X – volume: 382 start-page: 211 year: 2005 ident: 1051_CR35 publication-title: Neurosci lett doi: 10.1016/j.neulet.2005.03.053 – volume: 116 start-page: 11 year: 1985 ident: 1051_CR46 publication-title: Eur j pharmacol doi: 10.1016/0014-2999(85)90179-7 – volume: 101 start-page: 348 year: 2006 ident: 1051_CR21 publication-title: Addiction doi: 10.1111/j.1360-0443.2006.01314.x – volume: 311 start-page: 861 year: 2006 ident: 1051_CR4 publication-title: Science doi: 10.1126/science.1121218 – volume-title: World drug report 2007 year: 2007 ident: 1051_CR63 doi: 10.18356/58c4f2e4-en – volume: 30 start-page: 1138 year: 2005 ident: 1051_CR14 publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1300663 – volume: 90 start-page: 607 year: 1995 ident: 1051_CR20 publication-title: Addiction doi: 10.1046/j.1360-0443.1995.9056072.x – volume: 275 start-page: 1593 year: 1997 ident: 1051_CR56 publication-title: Science doi: 10.1126/science.275.5306.1593 – volume: 31 start-page: 1593 year: 2007 ident: 1051_CR49 publication-title: Prog neuro-psychopharmacol biol psychiatry doi: 10.1016/j.pnpbp.2007.08.040 – volume: 51 start-page: 141 year: 1998 ident: 1051_CR66 publication-title: Drug Alcohol Depend doi: 10.1016/S0376-8716(98)00072-6 – volume: 81 start-page: 18 year: 1983 ident: 1051_CR1 publication-title: Psychopharmacology doi: 10.1007/BF00439267 – volume: 20 start-page: 24 year: 2006 ident: 1051_CR17 publication-title: J Psychopharmacol doi: 10.1177/0269881105057000 – volume: 16 start-page: 1230 year: 1996 ident: 1051_CR37 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.16-03-01230.1996 – volume: 57 start-page: 1518 year: 1994 ident: 1051_CR54 publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp.57.12.1518 – volume: 10 start-page: 284 year: 2000 ident: 1051_CR53 publication-title: Cereb Cortex doi: 10.1093/cercor/10.3.284 – volume: 32 start-page: 950 year: 2007 ident: 1051_CR65 publication-title: Addict Behav doi: 10.1016/j.addbeh.2006.06.032 – volume: 22 start-page: 4563 year: 2002 ident: 1051_CR8 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.22-11-04563.2002 |
SSID | ssj0000484 ssj0068394 |
Score | 2.370653 |
Snippet | Rationale
Chronic drug use has been associated with increased impulsivity and maladaptive behaviour, but the underlying mechanisms of this impairment remain... Chronic drug use has been associated with increased impulsivity and maladaptive behaviour, but the underlying mechanisms of this impairment remain unclear. We... Rationale: Chronic drug use has been associated with increased impulsivity and maladaptive behaviour, but the underlying mechanisms of this impairment remain... |
SourceID | pubmedcentral proquest pubmed pascalfrancis crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 421 |
SubjectTerms | Adolescent Adult Aged Amphetamine - toxicity Amphetamine-Related Disorders - psychology Amphetamines Appetitive Behavior - drug effects Association Learning - drug effects Biological and medical sciences Biomedical and Life Sciences Biomedicine Brain research Central Nervous System Stimulants - toxicity Choice Behavior - drug effects Cocaine Cocaine - toxicity Cocaine-Related Disorders - psychology Cognition & reasoning Dopamine Uptake Inhibitors - toxicity Drug use Female Humans Male Medical sciences Middle Aged Motivation Neuropharmacology Neurosciences Opioid-Related Disorders - psychology Original Investigation Pharmacology Pharmacology. Drug treatments Pharmacology/Toxicology Probability Learning Psychiatry Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) Psychology. Psychoanalysis. Psychiatry Psychopharmacology Receptors, Serotonin - drug effects Reversal Learning - drug effects Reward Stereotyped Behavior - drug effects |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9wwEBZpAqUQSps-4qZJdSg5tDGVLNnynkoJDaGQkkMCezOyHnQh9W5jbyH_vjOWbLNtk8uyu5LwYz5pPjSjbwh5b_OZMzZTqRZcpJLDR-1rlkrtjGYeGK7GfciL78X5tfw2z-cxN6eNaZXDmtgv1HZpcI_8E7iiWQ7eJfu8-pVi0SgMrsYKGo_IDiqXIajVXE0LscQzmOFHAUQgKDILPE-Wl0OEk_WCohnWOEC5RMBoyjd81O5Kt_C6fKhz8T8i-m8-5V9B1d5XnT0jTyPJpF8CKp6TLdfskccXMYy-R44vg2D13Qm9ms5ftSf0mF5OUtZ3L4iL2rkUlk0NQ2m97miz7KiJ_2sAg-v0T2xbt44uWqqjwZ2luMlLV0Aw3W8XFMbpbZ-Tiw6TLhraVwhsX5Lrs69Xp-dpLMyQGlnmXaqNl9xn3OXOel9KzU3hrBaldDLPJKDCZ7Pc29ozmxmFoVGjC8uY5cBGnBevyHazbNw-oUAfea0yMxPMSl_aWpdKaQesiHmhVZEQNpiiMlG1HItn3FSj3nJvvQq_ovUqnpAP45BVkOx4qPPRhn3HEVhWXgBQEnIwGLyK07utRjAm5N3YCvMSgy26ccs1dGEFRp3V_T2KEqg0EKqEvA7wme62RCE7CddWG8AaO6Am-GZLs_jRa4MLBRRawGN9HCA43fW9L-HNg894QJ6EJBlMV3pLtrvbtTsEJtbVR_18-wMIVjEp priority: 102 providerName: ProQuest |
Title | Chronic cocaine but not chronic amphetamine use is associated with perseverative responding in humans |
URI | https://link.springer.com/article/10.1007/s00213-007-1051-1 https://www.ncbi.nlm.nih.gov/pubmed/18214445 https://www.proquest.com/docview/218958182 https://www.proquest.com/docview/20603047 https://www.proquest.com/docview/68566240 https://pubmed.ncbi.nlm.nih.gov/PMC3785131 |
Volume | 197 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9swED-2FsagjK378rplehh92GqwLdlyHpORrGw0hNFA9mRkfdDA5oTaKfS_352_QrZ2sJc4iSTH8Z10P-vufgfwwcRDq00kfcVD7osQX3KXB75QVqvAIcJVtA95MUvOF-LrMl62edxlF-3euSTrlbpPdiNzxH3aWkNMEPr4yHMY46M7xXEtotFu-RWUedl8SND8NzzMnLLI4rTza951vj3LdLRRJd4k11S3uAt-_h1F-YcrtbZQ06fwpIWWbNTowjN4YItjeHTROs-P4XTe0FTfnrHLXdZVecZO2XxHYH37HGzLmMtwsVQ4lOXbihXriun2e4UqYCv1i9q2pWWrkqlWzNYw2tplG4SV9sY2vOLsuo7EJTPJVgWr6wKWL2AxnVx-Pvfbcgy-Fmlc-Uo7EbootLE1zqVChTqxRvFUWBFHAnXBRcPYmdwFJtKSHKJaJSYITIgYxDr-Eg6KdWFfA0PQGOYy0kMeGOFSk6tUSmURCwWOK5l4EHSiyHTLVU4lM35mPctyLb2M3pL0stCDj_2QTUPU8a_Ogz359iOomDxHRfHgpBN41k7qMkM0NIwR4EQevO9bcTaSi0UVdr3FLkFCvmZ5f48kRQCNMMqDV4367K42Jfo6gb8t9xSr70BM4PstxeqqZgTnEoEzx7_1qVPB3VXfexPe_FfvE3jchMpQ0NJbOKiut_Yd4rEqH8BDuZQDOBxNx-MZHb_8-DbB43gym38f1LPzN0pVM20 |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VIgESQlBeptDuAXqAWqzttdc5IISAKqVN1UMq5eau9yEigRNqB5QfxX9kxq8oQHvrJUqyu443MzvzeWf2G4CXJh5YbULpqyiIfBHgS-5y7gtlteIOEa6ifcjRSTI8E18m8WQDfndnYSitsrOJtaE2M0175G_RFQ1i9C7h-_kPn4pGUXC1q6DRaMWRXf7CJ7by3eEnFO-rMDz4PP449NuiAr4WaVz5SjsRuDCwsTXOpUIFOrFGRamwIg4FzsiFg9iZ3HETaklhPa0Sw7kJ0JNaF-F1b8BN9LucnvXkRK4Mv6Azn82HBIFHwwAd0fm1OO0iqrwmMA2ppgLRM-Ka8IM1n3h3rkoUj2vqavwP-P6bv_lXELf2jQf34V4LatmHRgsfwIYttuDWqA3bb8HeaUOQvdxn49V5r3Kf7bHTFXX28iHYlquXoZlWOJTli4oVs4rp9nuFymcr9Z3aFqVl05KpVsGsYbSpzOYIaO1P2zCas4s6B5gcNJsWrK5IWD6Cs2uR2WPYLGaFfQoM4WqQy1APIm6ES02uUimVRRTGXaRk4gHvRJHpliWdinV8y3p-51p6Gb0l6WWBB6_7IfOGIuSqzjtr8u1HUBn7CBXFg-1O4FlrTsqsV34PdvtWtAMU3FGFnS2wC08oyi0v75GkCN0RwHnwpFGf1d2mRJwn8LflmmL1HYiDfL2lmH6tucgjiZA9wmm96VRwddeX_gnPrpzjLtwejkfH2fHhydE23GkSdChV6jlsVhcL-wJRYJXv1GuPwfl1L_Y_HmtwRg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VVKqQEILyMoV2D9AD1OraXj9yQAhoo5bSKEKt1JtZ70NEAifUDig_jX_HjJ8K0N56iZLsruPNzM583pn9BuCFDodGaT92ZeAFrvDwJbMZd4U0SnKLCFfSPuTpODo6Fx8vwos1-N2ehaG0ytYmVoZazxTtke-jKxqG6F38fdtkRUwORm_nP1wqIEWB1raaRq0hJ2b5C5_eijfHByjql74_Ojz7cOQ2BQZcJZKwdKWywrO-Z0KjrU2E9FRktAwSYUToC5yd9Yeh1Znl2lcxhfiUjDTn2kOvamyA170F6zE9FA1g_f3hePK5dwOCToDWHyKEITUfdECn2cKkja_yis7UpwoLRNaIK8T1VjzknbksUFi2rrLxPxj8bzbnXyHdylOO7sHdBuKyd7VO3oc1k2_CxmkTxN-E3UlNl73cY2f96a9ij-2ySU-kvXwApmHuZWi0JQ5l2aJk-axkqvleoiqaUn6ntkVh2LRgslE3oxltMbM5wlvz09T85uyyyggmd82mOavqExYP4fxGpPYIBvksN0-AIXj1sthXw4BrYROdySSOpUFMxm0g48gB3ooiVQ1nOpXu-JZ2bM-V9FJ6S9JLPQdedUPmNWHIdZ23V-TbjaCi9gEqigNbrcDTxrgUabcUHNjpWtEqUKhH5ma2wC48oph3fHWPKEEgj3DOgce1-vR3mxCNnsDfjlcUq-tAjOSrLfn0a8VMHsQI4AOc1utWBfu7vvJPeHrtHHdgAxd6-ul4fLIFt-tsHcqbegaD8nJhniMkLLPtZvEx-HLT6_0Pkuh14Q |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Chronic+cocaine+but+not+chronic+amphetamine+use+is+associated+with+perseverative+responding+in+humans&rft.jtitle=Psychopharmacology&rft.au=Ersche%2C+Karen+D&rft.au=Roiser%2C+Jonathan+P&rft.au=Robbins%2C+Trevor+W&rft.au=Sahakian%2C+Barbara+J&rft.date=2008-04-01&rft.issn=0033-3158&rft.volume=197&rft.issue=3&rft.spage=421&rft_id=info:doi/10.1007%2Fs00213-007-1051-1&rft_id=info%3Apmid%2F18214445&rft.externalDocID=18214445 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0033-3158&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0033-3158&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0033-3158&client=summon |